Oakbrook Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-4,830
| Closed | -$738K | – | 180 |
|
2019
Q4 | $738K | Sell |
4,830
-1,225
| -20% | -$187K | 0.15% | 206 |
|
2019
Q3 | $802K | Buy |
6,055
+1,300
| +27% | +$172K | 0.05% | 284 |
|
2019
Q2 | $675K | Sell |
4,755
-975
| -17% | -$138K | 0.04% | 336 |
|
2019
Q1 | $832K | Buy |
5,730
+50
| +0.9% | +$7.26K | 0.05% | 285 |
|
2018
Q4 | $643K | Sell |
5,680
-812
| -13% | -$91.9K | 0.04% | 313 |
|
2018
Q3 | $873K | Buy |
6,492
+1,550
| +31% | +$208K | 0.05% | 323 |
|
2018
Q2 | $555K | Sell |
4,942
-555
| -10% | -$62.3K | 0.04% | 331 |
|
2018
Q1 | $587K | Buy |
5,497
+320
| +6% | +$34.2K | 0.04% | 321 |
|
2017
Q4 | $567K | Buy |
5,177
+660
| +15% | +$72.3K | 0.04% | 331 |
|
2017
Q3 | $488K | Buy |
4,517
+400
| +10% | +$43.2K | 0.03% | 347 |
|
2017
Q2 | $416K | Buy |
+4,117
| New | +$416K | 0.03% | 362 |
|
2017
Q1 | – | Sell |
-5,042
| Closed | -$384K | – | 537 |
|
2016
Q4 | $384K | Buy |
5,042
+150
| +3% | +$11.4K | 0.03% | 408 |
|
2016
Q3 | $408K | Hold |
4,892
| – | – | 0.02% | 392 |
|
2016
Q2 | $403K | Buy |
4,892
+1,050
| +27% | +$86.5K | 0.02% | 405 |
|
2016
Q1 | $292K | Sell |
3,842
-500
| -12% | -$38K | 0.02% | 438 |
|
2015
Q4 | $349K | Buy |
4,342
+100
| +2% | +$8.04K | 0.02% | 411 |
|
2015
Q3 | $269K | Hold |
4,242
| – | – | 0.02% | 463 |
|
2015
Q2 | $298K | Buy |
4,242
+150
| +4% | +$10.5K | 0.02% | 449 |
|
2015
Q1 | $324K | Buy |
4,092
+200
| +5% | +$15.8K | 0.02% | 454 |
|
2014
Q4 | $248K | Hold |
3,892
| – | – | 0.01% | 499 |
|
2014
Q3 | $233K | Sell |
3,892
-400
| -9% | -$23.9K | 0.01% | 477 |
|
2014
Q2 | $230K | Sell |
4,292
-100
| -2% | -$5.36K | 0.01% | 545 |
|
2014
Q1 | $265K | Sell |
4,392
-100
| -2% | -$6.03K | 0.01% | 513 |
|
2013
Q4 | $238K | Sell |
4,492
-300
| -6% | -$15.9K | 0.01% | 540 |
|
2013
Q3 | $222K | Sell |
4,792
-700
| -13% | -$32.4K | 0.01% | 550 |
|
2013
Q2 | $225K | Buy |
+5,492
| New | +$225K | 0.01% | 603 |
|